关键词: Antibiotic susceptibilities Contact lens Pseudomonas aeruginosa microbial keratitis

Mesh : Adolescent Adult Anti-Bacterial Agents / therapeutic use Bacteria / isolation & purification Contact Lenses / adverse effects Corneal Ulcer / drug therapy epidemiology microbiology physiopathology Eye Infections, Bacterial / drug therapy epidemiology microbiology physiopathology Female Humans Male Microbial Sensitivity Tests Middle Aged Retrospective Studies Risk Factors Singapore / epidemiology Tertiary Care Centers Visual Acuity / physiology Young Adult

来  源:   DOI:10.1016/j.clae.2019.02.006   PDF(Sci-hub)

Abstract:
To investigate the disease patterns of Microbial Keratitis(MK) in patients seen in a tertiary referral hospital, to evaluate the clinical outcomes of MK and the risk factors for poorer visual outcomes.
This is a retrospective case series of all culture-positive corneal scrapings between April 2012 and October 2016. A total of 230 patients(n = 230) were included into this study. Patient demographics, clinical information and microbiological characteristics of organisms are collected.
64.3% of patients with MK are contact lens(CL) users. Among CL users, there is a preponderance of females(68.9%) and they tend to be younger (27.1 ± 10.6 years). The most frequently isolated organism in this study is Pseudomonas aeruginosa(51.7%) with 69.6% of cases belonging to CL users. MK in non-CL users tend to involve other organisms, such as coagulase-negative Staphylococci, Staphylococcus aureus and Streptococcus pneumoniae. Pseudomonas aeruginosa exhibits good sensitivity rates to ciprofloxacin, levofloxacin and gentamicin. Non-Pseudomonas organisms display similar sensitivities to ciprofloxacin, levofloxacin and gentamicin. MK in non-CL users is related to predisposing factors of prior ocular trauma and concomitant ocular pathology. They tend to have worse visual acuity(VA) on presentation and after treatment compared to CL users. Poorer VA outcome is associated with larger ulcers, increasing age, trauma and non-CL wearers. Successful clinical outcome is achieved in 97.8% of patients, with only 2.2% requiring further surgical intervention.
CL use alters the disease patterns of MK as well as the underlying microbiological etiology. Fluoroquinolones and aminoglycosides are good empirical antibiotics for MK treatment. Early referral to a tertiary centre will likely allow for earlier treatment, which can result in better VA outcome, especially so in patients who are older, non-CL wearers and have larger ulcers with associated trauma.
摘要:
暂无翻译
公众号